Showing results (761-770 of 806) with videos related to
Sort By:
Pageof 81
NEJM Evidence|August 26, 2025
In-Hospital Mortality in Hemorrhagic Myocardial InfarctionKeyur P Vora, Ankur Kalra, Chirag D Shah, et al.Nature Communications|November 14, 2019
ZEB1/NuRD complex suppresses TBC1D2b to stimulate E-cadherin internalization and promote metastasis in lung cancerRoxsan Manshouri, Etienne Coyaud, Samrat T Kundu, et al.Blood Advances|June 9, 2022
Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolismPhilip S Wells, Tobias Tritschler, Faizan Khan, et al.Journal of Thrombosis and Haemostasis : JTH|August 6, 2025
Racial Disparities in the Incidence and Risk Factors for Major Bleeding during Extended Anticoagulant Therapy for Venous ThromboembolismDuale Omar, Michael J Kovacs, Alejandro Lazo-Langner, et al.Annals of Internal Medicine|March 5, 2009
Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trialMark A Crowther, Walter Ageno, David Garcia, et al.Blood|September 16, 2008
Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trialClive Kearon, Jim A Julian, Michael J Kovacs, et al.Health Policy and Planning|April 25, 2024
Does pay-for-performance design matter? Evidence from BrazilLetícia Xander Russo, Timothy Powell-Jackson, Josephine Borghi, et al.The New England Journal of Medicine|August 15, 2003
Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolismClive Kearon, Jeffrey S Ginsberg, Michael J Kovacs, et al.Journal of Thrombosis and Haemostasis : JTH|June 27, 2025
Performance of clinical decision rules in patients presenting with suspected recurrent venous thromboembolism: a multicenter prospective cohort studyVicky Mai, Emily S L Martens, Marc Righini, et al.The New England Journal of Medicine|December 13, 2017
Edoxaban for the Treatment of Cancer-Associated Venous ThromboembolismGary E Raskob, Nick van Es, Peter Verhamme, et al.Pageof 81